Facilitated By

San Antonio Medical Foundation

COVID-19 CTA: Preclinical models for SARS-CoV-2 infection

Texas Biomedical Research Institute


As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.

Principal Investigator(s)
Torrelles, Jordi B
Funded by
Bill & Melinda Gates Foundation
Research Start Date

The overall scope of the study is to determine if human monoclonal antibodies (hmAbs) shown in vitro to block SARS-CoV-2 infection are also effective, alone or in combination, in vivo using two rodent animal models of SARS-CoV-2 infection and associated COVID-19 disease.

Collaborative Project
Basic Research
Infectious Disease